XiAn Libang Pharmaceutical Co.,Ltd.

Business Type:Manufacturer

Main Products:Propofol,Propofol injectable emulsion,Fat Emulsion,Fulvestrant,Tranexamic acid,Ropivacaine HCl ,Diatrizoic Acid ,Meglumine

Country/Region:China

Annual Revenue:600000000 USD

Year Established:1996

Main Markets:North America,South America,Southeast Asia,Eastern Asia,

Ddu Verified

HOT Rank

6/10
Company Information

XI’AN LIBANG PHARMACEUTICAL CO.,LTD. founded in 1996 with the location at Xi’an of China, the centre of the northwest pharmaceutical industry, is specialized in research, development, production and distribution of generic Finished Dosage Forms and high-valued APIs. As the first and also largest supplier of generic Propofol in China, LIBANG started its business and subsequently launched a broad portfolio products covering anesthetics, cardiovascular, antineoplastic, clinical nutrition etc.

With more than 10 years growth, LIBANG has transformed into an integrated healthcare solution provider, LIBANG HEALTHCARE GROUP, with diversified fields covering APIs, pharmaceutical excipients, prescription drugs, OTC products, biomedicine, medical devices, etc. LIBANG is a technology-driven firm, with more than 8% of the annual sales revenues devoted to R&D, established a unique R&D platform to proactively follows the latest pharmaceutical technology frontier.

LIBANG now is one of Top 100 China’s Pharmaceutical Industries and also listed in the Top 20 The Most Potential Chinese Pharmaceuticals that was rated by the IMS Health. 


Email to this supplier
To

Send

Inquiry Cart(0)